Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis

AL Funk, Y Lu, K Yoshida, T Zhao… - The Lancet Infectious …, 2021 - thelancet.com
Background To eliminate mother-to-child transmission (MTCT) of hepatitis B virus (HBV),
peripartum antiviral prophylaxis might be required for pregnant women infected with HBV …

[HTML][HTML] Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices

S Schillie - MMWR. Recommendations and reports, 2017 - cdc.gov
Hepatitis B virus (HBV) is transmitted via blood or sexual contact. Persons with chronic HBV
infection are at increased risk for cirrhosis and liver cancer and require medical care. This …

Tenofovir versus placebo to prevent perinatal transmission of hepatitis B

G Jourdain, N Ngo-Giang-Huong… - … England Journal of …, 2018 - Mass Medical Soc
Background Pregnant women with an elevated viral load of hepatitis B virus (HBV) have a
risk of transmitting infection to their infants, despite the infants' receiving hepatitis B immune …

[HTML][HTML] Eradicating hepatitis B virus: the critical role of preventing perinatal transmission

CE Stevens, P Toy, S Kamili, PE Taylor, MJ Tong… - Biologicals, 2017 - Elsevier
Prevention of hepatitis B virus (HBV) transmission from infected mothers to their newborns is
critical to HBV control and eventual eradication. Mother-to-child perinatal transmission …

[HTML][HTML] Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads

Y Lin, Y Liu, G Ding, L Touqui, W Wang, N Xu, K Liu… - Scientific reports, 2018 - nature.com
Mother-to-child transmission is the major cause of chronic hepatitis B virus (HBV) infection.
This double-blind trial tested the effect of tenofovir disoproxil fumarate (TDF) in preventing …

Maternal and infant bone mineral density 1 year after delivery in a randomized, controlled trial of maternal tenofovir disoproxil fumarate to prevent mother-to-child …

N Salvadori, B Fan, W Teeyasoontranon… - Clinical Infectious …, 2019 - academic.oup.com
In a randomized, double-blind, placebo-controlled trial of tenofovir disoproxil fumarate (TDF)
use from 28 weeks gestational age to 2 months postpartum to prevent mother-to-child …

[HTML][HTML] Efficacy and safety of tenofovir in preventing mother-to-infant transmission of hepatitis B virus: a meta-analysis based on 6 studies from China and 3 studies …

W Li, L Jia, X Zhao, X Wu, H Tang - BMC gastroenterology, 2018 - Springer
Background The vertical transmission of HBV from mothers to their infants at birth or in early
infancy has a significant role in the endemicity of HBV infection. Tenofovir is one of the most …

Altered expression of endosomal Toll‐like receptors and HBeAg seropositivity may act synergistically towards the vertical transmission of HBV

S Kalita, MJ Kalita, G Hazarika, PP Das… - American Journal of …, 2023 - Wiley Online Library
Problem Hepatitis B is one of the leading causes of mortality in India. Despite the mass
vaccination programme, the burden of the infection is still increasing due to its vertical …

Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real‐life practice

J Liu, J Wang, T Yan, D Du, C Qi, F Cao… - Journal of viral …, 2019 - Wiley Online Library
Mother‐to‐child transmission (MTCT) is a major obstacle in the elimination of hepatitis B
virus (HBV) infection. Telbivudine (LdT) and tenofovir disoproxil fumarate (TDF) are the two …

Hepatitis B Infection and Mother‐to‐Child Transmission in Haiphong, Vietnam: A Cohort Study with Implications for Interventions

PM Khue, NT Thuy Linh, VH Vinh… - BioMed research …, 2020 - Wiley Online Library
Background. There is little data available on HBV infection and mother‐to‐child transmission
(MTCT) in Vietnam. Objective. This study is aimed at assessing the prevalence of HBV …